Related Experiment Video
Updated: Aug 8, 2026
07:50
Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
New antimycobacterial S-alkylisothiosemicarbazones
K Waisser1, L Heinisch, M Slosárek
1Department of Inorganic and Organic Chemistry, Charles University, Faculty of Pharmacy, Hradec Králové, Czechia. waisser@faf.cuni.cz
Folia Microbiologica
|May 10, 2006
Summary
Researchers screened 12 S-alkylisothiosemicarbazones for antimycobacterial activity. One compound demonstrated superior efficacy against pathogenic strains compared to isoniazid, offering a potential new avenue for tuberculosis treatment.
Area of Science:
- Medicinal Chemistry
- Microbiology
- Pharmacology
Background:
- Antimycobacterial agents are crucial for treating infections caused by Mycobacterium species.
- Drug resistance in Mycobacterium tuberculosis necessitates the development of novel therapeutic compounds.
- Pathogenic nontuberculous mycobacteria also pose significant clinical challenges.
Purpose of the Study:
- To systematically evaluate a series of 12 S-alkylisothiosemicarbazones for in vitro antimycobacterial activity.
- To identify novel compounds with potent activity against clinically relevant mycobacterial strains.
- To compare the efficacy of synthesized compounds against standard antimycobacterial drugs.
Main Methods:
- Synthesis and characterization of 12 S-alkylisothiosemicarbazone derivatives.
- In vitro susceptibility testing against Mycobacterium tuberculosis, Mycobacterium kansasii, Mycobacterium fortuitum, Mycobacterium intracellulare, and Mycobacterium avium.
- Comparative analysis of compound activity against the standard drug isoniazid.
Main Results:
- One compound, Quinoline-4-carbaldehyde-S-hexyl-isothiohydrazone, exhibited significant in vitro activity.
- This compound demonstrated greater potency against pathogenic mycobacterial strains than the reference drug isoniazid.
- The study identified specific S-alkylisothiosemicarbazones with promising antimycobacterial profiles.
Conclusions:
- S-alkylisothiosemicarbazones represent a promising class of compounds for antimycobacterial drug discovery.
- Quinoline-4-carbaldehyde-S-hexyl-isothiohydrazone warrants further investigation as a potential therapeutic agent.
- The findings contribute to the ongoing search for effective treatments against mycobacterial infections.
Related Concept Videos
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
02:17Structure and Nomenclature of Thiols and Sulfides
Thiols and sulfides are sulfur analogs of alcohols and ethers, respectively, where the sulfur atom takes the place of the oxygen atom. Thus, thiols are generally represented as RSH, where R is an alkyl substituent and —SH is the functional group. On the other hand, in sulfides, the central sulfur atom is bonded to two hydrocarbon groups on either side. Depending upon the type of group, sulfides can be either symmetrical or asymmetrical. Both thiols and sulfides display a bent geometry, similar...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
02:26Preparation and Reactions of Sulfides
Sulfides are the sulfur analog of ethers, just as thiols are the sulfur analog of alcohol. Like ethers, sulfides also consist of two hydrocarbon groups bonded to the central sulfur atom. Depending upon the type of groups present, sulfides can be symmetrical or asymmetrical. Symmetrical sulfides can be prepared via an SN2 reaction between 2 equivalents of an alkyl halide and one equivalent of sodium sulfide.
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...